Epizyme Total Non Current Liabilities 2011-2025 | EPZM

Annual Total Non Current Liabilities Epizyme

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	245 M	59.1 M	4.66 M	29.3 M	29.1 M	29.9 M	21.9 M	24.1 M	119 M	76.7 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
245 M	4.66 M	63.9 M

Total Non Current Liabilities of other stocks in the Biotechnology industry

Issuer	Total Non Current Liabilities	Price	% 24h	Market Cap	Country
ARCA biopharma ABIO	409 K	-	1052.0 %	$ 415 M	USA
Amphastar Pharmaceuticals AMPH	69.4 M	$ 25.27	-2.43 %	$ 1.22 B	USA
Alpine Immune Sciences ALPN	15.9 M	-	-	$ 2.17 B	USA
Arbutus Biopharma Corporation ABUS	25.6 M	$ 4.75	1.61 %	$ 788 M	Canada
Aclaris Therapeutics ACRS	5.95 M	$ 3.26	-3.12 %	$ 252 M	USA
AlloVir ALVR	5.46 M	-	4.14 %	$ 49.1 M	USA
Acasti Pharma ACST	12.2 M	-	4.01 %	$ 150 M	Canada
Adaptimmune Therapeutics plc ADAP	23.6 M	-	-15.15 %	$ 60.3 M	Britain
Ampio Pharmaceuticals AMPE	3.53 M	-	-11.43 %	$ 502 K	USA
Aeglea BioTherapeutics AGLE	4.74 M	-	-	$ 1.01 B	USA
Alexion Pharmaceuticals, Inc. ALXN	4.83 B	-	-	$ 40.3 B	USA
Ascendis Pharma A/S ASND	101 M	$ 220.27	4.81 %	$ 5 B	Danmark
Albireo Pharma ALBO	79.1 M	-	-0.23 %	$ 916 M	USA
Ayala Pharmaceuticals AYLA	553 K	-	-	$ 7.46 M	Israel
Aptorum Group Limited APM	2.21 M	$ 1.29	-3.01 %	$ 7.03 M	China
Alterity Therapeutics Limited ATHE	73.6 K	$ 3.3	-3.51 %	$ 7.94 B	Australia
EyeGate Pharmaceuticals, Inc. EYEG	6.39 M	-	-1.52 %	$ 24.7 M	USA
AstraZeneca PLC AZN	30.8 B	$ 89.78	-0.57 %	$ 96.9 B	Britain
Anika Therapeutics ANIK	26.1 M	$ 9.57	0.84 %	$ 140 M	USA
Brickell Biotech BBI	146 K	-	-5.38 %	$ 6.06 M	USA
BeiGene, Ltd. BGNE	374 M	-	0.49 %	$ 251 B	Cayman-islands
Bellicum Pharmaceuticals BLCM	48 M	-	-9.72 %	$ 5.89 M	USA
Berkeley Lights BLI	22.3 M	-	-7.31 %	$ 87 M	USA
Benitec Biopharma BNTC	213 K	$ 12.05	-7.06 %	$ 496 M	USA
Aytu BioScience AYTU	42.1 M	$ 2.34	2.59 %	$ 14.7 M	USA
Arena Pharmaceuticals ARNA	52.2 M	-	-6.81 %	$ 3.04 B	USA
Baudax Bio BXRX	65.4 M	-	0.59 %	$ 63 K	USA
Avenue Therapeutics ATXI	2.03 M	-	-52.27 %	$ 4.45 M	USA
Can-Fite BioPharma Ltd. CANF	1.63 M	$ 0.28	-2.28 %	$ 609 M	Israel
Институт стволовых клеток человека ISKJ	541 M	-	-	-	Russia
Catalyst Biosciences CBIO	981 K	$ 14.01	-8.49 %	$ 922 M	USA
ChromaDex Corporation CDXC	5.46 M	-	-0.88 %	$ 598 M	USA
Axon Enterprise AXON	107 M	$ 566.18	-2.56 %	$ 42.9 B	USA
Cerus Corporation CERS	58.1 M	$ 2.16	0.47 %	$ 399 M	USA
Checkpoint Therapeutics CKPT	2.47 M	-	-	$ 169 M	USA
Caladrius Biosciences CLBS	254 K	-	-16.75 %	$ 25.8 M	USA
Clovis Oncology CLVS	579 M	-	-7.23 %	$ 13 M	USA
Biogen BIIB	9.03 B	$ 174.42	1.11 %	$ 25.4 B	USA
BioVie BIVI	62.5 K	$ 1.42	-5.96 %	$ 2.1 M	USA
Celldex Therapeutics CLDX	17.3 M	$ 27.36	-2.09 %	$ 1.76 M	USA
Cortexyme CRTX	208 K	-	-1.05 %	$ 67.1 M	USA
Cellectar Biosciences CLRB	422 K	$ 3.63	-3.97 %	$ 44.4 M	USA
Deciphera Pharmaceuticals DCPH	15.9 M	-	-	$ 2.18 B	USA
Biohaven Pharmaceutical Holding Company Ltd. BHVN	802 M	$ 11.54	0.87 %	$ 746 M	USA
BioNTech SE BNTX	341 M	$ 94.73	-1.32 %	$ 27.2 B	Germany
Eloxx Pharmaceuticals ELOX	5.24 M	-	-5.68 %	$ 8.28 M	USA
Acer Therapeutics ACER	244 K	-	2.71 %	$ 14 M	USA
Enochian Biosciences ENOB	425 K	-	-	$ 40.5 M	USA
Acorda Therapeutics ACOR	257 M	-	-24.86 %	$ 820 K	USA